Gordon Dunn serves as Executive at Quoin Pharmaceuticals, Ltd., where they oversee executive responsibilities. Since joining the company, Gordon Dunn has executed 5 insider transactions totaling $23.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 10, 2024 involved purchasing 10,000 shares valued at $7.1K.
Gordon Dunn currently holds 28,856 shares of Quoin Pharmaceuticals, Ltd. (QNRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gordon Dunn has been a net buyer of QNRX stock. They have purchased $23.2K and sold $0 worth of shares.
Gordon Dunn's most recent insider trade was on Sep 10, 2024, when they purchased 10,000 shares at $0.71 per share.
Get notified when new Form 4 filings are submitted
| $0.91 |
| Discretionary |
| Sep 9, 2024 | QNRX | $685 | Purchase | 856 | $0.80 | Discretionary |
| Sep 9, 2024 | QNRX | $3.1K | Purchase | 4,000 | $0.78 | Discretionary |
| Sep 9, 2024 | QNRX | $3.2K | Purchase | 4,000 | $0.80 | Discretionary |